WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 21 07 17A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Mr K, pictured, is seeing improvement in all areas affected by male pattern hair loss.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article

Turkish doctors have found that low levels of vitamin D in children can worsen and prolong hair loss that is caused by the autoimmune disorder Alopecia Areata.

Their findings confirm long-held beliefs that vitamin D can play a part in Alopecia Areata, and while the team does not suggest that low levels of vitamin D directly cause the condition, its tests do confirm, it says, that the severity of the disease, the number of patches and the disease duration can be aggravated by low levels of the vitamin.

Eggs for Hair Health

Egg yolks are one of the only food sources of vitamin D

Vitamin levels compared

The researchers, who are based at the Konya Numune Hospital in the city of Konya, south of Ankara, looked at the vitamin D levels of 20 paediatric patients with Alopecia Areata and compared them with 34 children who were not losing their hair.

Significant, negative correlations were seen for vitamin D concentration with the Severity of Alopecia Tool score (P < 0.001; r, −0.831), number of patches (P < 0.001; r, −0.989), and disease duration (P < 0.001 and r, −0.997).

In summing up, the researchers stated: “Vitamin D deficiency is not the only etiologic factor in AA pathogenesis, but in the presence of other etiological factors, this deficiency can aggravate AA severity, and thus, vitamin D supplementation may be beneficial in treatment of paediatric AA.”

But why does vitamin D play a part? Unsurprisingly, the answer is complex – as the Turkish doctors note: “Besides playing an important role in calcium homeostasis and bone health, 1,25-dihydroxyvitamin D [1,25(OH)2D3] is a modulator of immune systems via its varied effects on cells expressing vitamin D receptors (VDRs) such as T and B lymphocytes, dendritic cells, and macrophages.”

They also suggest that a vitamin D deficiency might be an environmental trigger for the induction of autoimmunity – meaning that it might “kick-start” a condition that may otherwise effectively lay dormant. Other experts have wondered much the same thing – though there are always two ways of looking at things. As one doctor in Houston recently admitted, it may be that people with Alopecia Areata have low levels of vitamin D because they are less inclined to go outdoors for fear of being looked at (vitamin D is made by skin that has been exposed to sunlight).

It’s also safe to say that no studies have yet shown that giving people with Alopecia Areata vitamin D supplements actually improves their prognosis.

Time helps in many cases

What does tend to lead to improvements is time: in many cases patchy hair loss caused by the disorder will grow back in a few months, although this isn’t always the case and the number of patches can increase.

Alopecia Areata treatment at a specialist hair loss clinic begins with a conversation about what the trigger event that caused the autoimmune disorder may be. Several such triggers are commonly thought to initiate the condition, including psychological long-term stress, physical trauma and sudden shock. A genetic link is also suspected, though the precise cause of autoimmune hair loss remains unknown.

At Belgravia, this peek into a client’s history and lifestyle is followed up with a tailored treatment course that makes use of high strength minoxidil and a number of hair growth boosters such as the vitamin and mineral supplement, Hair Vitalics which contain vitamin D.


The Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article
24 Jul

‘Is Hair Loss From Smoking Permanent?’

July 24th, 2017 by

under Hair Loss, hairlossANSWERS, Women's Hair Loss | Comments Off on ‘Is Hair Loss From Smoking Permanent?’ | Ask A Question

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Theresa

Question: I quit smoking a few months ago. Will I see any difference in my hair or Does smoking cause permanent damage?

Answer: Hi, Theresa. For the purposes of answering your question we’re assuming that you are experiencing hair loss and believe it may be linked to smoking.

Many Young Women Class Themselves as Light SmokersVarious studies and theories have linked smoking to hair fall, mostly due to the negative effects it is believed to have on the hair growth cycle by worsening circulation and leeching nutrients from the blood.

When it comes to smoking and hair loss, we would need to examine you before confirming what precisely was causing your shedding. Giving up smoking is a great step for both your hair and your general health, however, so is certainly beneficial.

Smoking cigarettes has been linked to both temporary hair loss from Telogen Effluviumand the permanent hair loss conditions male pattern baldness and female pattern hair loss. The easiest way to tell which you may be experiencing is to note the location of the hair thinning.

Telogen Effluvium causes hair fall from all over the scalp. This is a temporary hair loss condition that generally clears up naturally within around six months though telogen effluvium treatment can help to speed this process along. It is often caused by underlying lifestyle issues, such as dietary imbalances or stress, and illness.

Female pattern hair loss is a permanent, genetic condition which is inherited. It causes thinning hair around the top of the scalp in women, which is often most noticeable along the parting and at the temples. If this condition is already present, then smoking is believed to be able to worsen it by increasing the level and rate of shedding. If it is not already active but there is an existing genetic predisposition to this type of female hair loss, it can be triggered by a bout of Telogen Effluvium. Female Pattern Hair Loss Treatment can help to prevent further hair fall and regrow hair in these cases.

It is also possible for both hair loss conditions to present simultaneously. In this instance it is likely that you would notice thinning hair all over your scalp which is worse along the vertex, crown and hairline. A Belgravia hair loss specialist can tailor a bespoke treatment course featuring recommended formulations of high strength minoxidil and boosters such as the exclusive Hair Vitalics for Women hair growth supplement, to treat both complaints at once.

In order to know which approach to take, we recommend you have a consultation in order to receive a professional diagnosis. Once the cause of your hair loss has been pinned down, personalised treatment recommendations can be made and any further queries you have can be answered. In the meantime, congratulations on giving up smoking and we wish you the very best of luck in keeping it up.


Circ - Belgravia Centre Hair Growth supplements boosters lasercombThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

A trial into the use of a modified bone cancer drug as a possible treatment for people with the autoimmune disorder Alopecia Areata, which leads to sudden, patchy hair loss, has been green-lit to continue by America’s Food and Drug Administration.

The FDA had caused some concern among investors in US company Concert Pharmaceuticals when it put a temporary halt on a trial into its variation on the JAK inhibitor drug ruxolitinib as a possible treatment for Alopecia Areata. Ruxolitinib is also known by its current brand names Jakafi or Jakavi; it is currently prescribed in oral form for conditions such as myelofibrosis. It is being explored as a topical drug for Alopecia Areata after clinical trials in the USA discovered the topical formulation to be potentially more effective than an oral tablet.

Less than two months after the FDA-sanctioned halt was called, Massachusetts-based Concert has amended the scope of the trial into its orally-administered CTP-543 drug and been allowed to proceed.

food-and-drug-administration-usa-fdaDesign of trial modified

Roger Tung, Concert’s CEO, said: ““We believe the FDA is taking a measured approach for the development of Janus kinases inhibitors, or JAK inhibitors, for autoimmune dermatological disorders, including alopecia areata. Accordingly, we agreed to modify the design of our Phase IIa trial to evaluate CTP-543 in the patient population in a more step-wise fashion.”

Specifically, Concert has agreed to test low doses of the drug – 4mg and 8mg twice daily, or a placebo – before they will consider whether it is safe to increase it. Adds Tung: ‘It is important to note that CTP-543 has been well-tolerated in clinical evaluation to date and demonstrates a non-clinical safety profile consistent with JAK inhibition.”

The company plans on using a group of around 100 volunteers with patchy hairloss caused by Alopecia Areata for the double-blind trial. Though ruxolitinib itself has shown a great deal of promise as a possible future treatment option for the condition during its numerous clinical trials to date, Concert’s deuterated ruxolitinib drug may have the potential to offer patients a less-frequent dose regimen. This is because it has been engineered to have a longer half life than regular ruxolitinib, or, simply put, it should remain in the bloodstream for longer.

Drugs need to be proven

Studies into possible new treatments for the autoimmune disorder – which affects at least two per cent of all people in their lifetime – are ongoing at multiple locations around the world, though as all drugs need to be proven to be both safe and effective before they are cleared/licensed by the regulatory bodies of whichever countries they are intended for sale, it is a necessarily slow business.

At Belgravia, Alopecia Areata treatment is currently offered in the form of topical applications of the drug high strength minoxidil which has been seen to often produce highly effective results in regrowing hair on the scalp. Minoxidil is licensed by the MHRA for use on pattern hair loss in men and women, though it has also resulted in many success stories when used to treat Alopecia Areata.


Circ - Minoxidil iconThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Cold cap devices which chill the scalp during cancer treatment in order to help reduce hair loss are to be offered to more and more patients in the US following a new government ruling.

The US Food and Drug Administration (FDA) has cleared a device named the DigniCap Cooling System for use on people with different types of cancer than those it is already cleared for.

The Dignicap Scalp Cooling SystemStudy on 122 women

Since 2015, DigniCap’s device has been cleared for use on patients with breast cancer following a study on 122 women with the disease who were undergoing chemotherapy. This study showed that two thirds of those who wore the device during treatment lost less than half of their hair.

In support of the expanded use of the device, DigniCap submitted evidence from published, peer-reviewed articles that analysed the application of the DigniCap to cancer patients with solid tumours in other areas of the body.

This data was deemed by the FDA to be sufficient scientific evidence to support the safety and efficacy of DigniCap for expanded use.

“We are pleased to expand the use of this product for cancer patients with solid tumours to potentially minimise chemotherapy-induced hair loss,” said Binita Ashar, M.D., director, Division of Surgical Devices, in the FDA’s Center for Devices and Radiological Health. “Managing the side effects of chemotherapy is a critical component to overall health and quality of life.”

Total baldness possible

The side effects she mentions do include hair loss in a great many cases, as drugs designed to treat tumours are often unable to detect between healthy cells and cancerous ones and can cause damage to hair follicles, which leads to thinning. This can range from patchy hair loss to rather more severe shedding and even total baldness.

The cold cap chills the scalp to an optimal temperature to significantly reduce the flow of blood around that region. As the circulation reduces locally, so too does the likelihood that the cancer drugs will wreak havoc with the hair follicles, preventing hair fall. It can be a huge boon to people undergoing chemotherapy treatment, as when people are already feeling especially vulnerable and often physically weakened by their exposure to cancer drugs, the highly visible sign of losing their hair can often feel like the ultimate slap in the face.

The downside of cold caps is that they can be rather uncomfortable to wear due to the low temperatures involved, though few people seem to find them unbearable. There’s also no guarantee that hairloss won’t happen. Trials by UK company Paxman, however, have shown them to be very effective, and their own device – the Paxman Scalp Cooling System – claims an 89 per cent success rate on breast cancer patients.

When hair is lost to cancer drugs it usually grows back in a matter of months, though it can take up to a year for a full head of hair to properly regrow. A strange quirk of chemotherapy treatment is that hair quite often grows back slightly differently to how it was before – once-light hair can return slightly darker, and curls where hair used to be straight are common, too. Fortunately, this is usually only temporary, lasting around a couple of hair growth cycles.


The Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert alopecia areata ophaisic and alopecia areata belgravia centre 20 07 17A new entry has just been added to Belgravia’s Alopecia Areata Treatment Success Stories gallery. In this particular case, the condition is referred to as Ophiasic Alopecia Areata due to the pattern.

Ms Price, pictured, is very pleased to see lots of new growth in the affected areas.

Find out what she had to say and see her regrowth results close up, or find out more about treating Alopecia Areata by clicking the buttons below…

 

VIEW SUCCESS STORY

TreatmenT information 

 


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article

A pharmaceutical company in the US has announced the results of a small UK trial into a new injection-based treatment for people with genetic hair loss.
Kerastem body fat scalp injectins hair loss treatment
Kerastem, whose website poses the question “What if your body had the power to grow your hair back?”, has been exploring the idea that modified body fat that is re-injected back into the scalp could encourage new hairs to grow. It has recruited around 70 people for a major study into possible new treatment options for male pattern baldness and female pattern hair loss which it has named the STYLE trial; the UK study appears to be something of a precursor to this.

Body fat solution injected into scalp

According to a press release from the company: “All six (100%) subjects receiving Kerastem Therapy had an increase from baseline hair counts at six months, with initial results as early as six weeks.”

The trial saw doctors perform single scalp injections of Kerastem Cell Therapy in nine healthy hair loss patients, of whom six were followed for a total of six months.

Those six volunteers saw a mean increase of 31 hairs per cm2 of scalp at 24 weeks, compared to baseline, which equated to an increase of 23 per cent. One or more of the subjects reportedly saw up to a 53 per cent increase – which naturally means that at least one other subject had a growth rate somewhat lower than 23 per cent as well. The individual results have not been released at this time.

Said lead investigator Dr David Perez-Meza: “We are very pleased with the clinical outcomes of our hair regeneration study, as they represent this procedure is safe and that results are on par or better than those of traditional medical approaches to hair loss.”

The STYLE trial proper is currently underway and Dr Eric Daniels, chief medical officer at Kerastem, says he looks forward to releasing top-line, 24-week data from it later this year. He added that: “Fat and fat derived cells are now appreciated as a dynamic and vital participant in the normal cycle of hair growth.”

His words echo those of proponents of a broadly similar treatment in which Platelet-Rich Plasma (PRP) is removed from a patient’s blood and then re-injected back into the scalp, where its “growth factors” are said to encourage new hairs to grow. With adipose fat, it is cell-enriched tissue that is delivered to the scalp.

Not a good option for the squeamish

Injections like these are regarded by many experts in the field of hair loss as secondary treatment options that, once their safety and efficacy has been clinically-proven, may work well when used alongside currently MHRA and FDA-approved options for androgenetic alopecia. This invasive option is not well suited to the squeamish, however, though Belgravia offers a range of hair growth boosters which can are effective and non-invasive.

The only two genetic hair loss drugs that have attained this gold standard of MHRA and FDA approval to date are finasteride 1mg and minoxidil.

The one-a-day oral tablet finasteride 1mg is currently only deemed suitable for men over the age of 18 an is not prescribed for women. It works by inhibiting the formation of DHT, the testosterone-byproduct which physically causes hair thinning in cases of pattern hair loss. It binds to the follicles around the top of the scalp in genetically predisposed individuals, gradually weakening and destroying them, causing the outward signs of thinning hair, hair loss and potentially eventual baldness. Finasteride 1mg is a popular component in male pattern hair loss treatment courses at Belgravia, for men interested in preventing baldness.

Both men and women wanting to undergo treatment for female pattern hair loss can use minoxidil, as long as they are medically approved to do so and are aged 16 or over. It is a topically-applied medication that is often used by men in combination with finasteride 1mg. Belgravia clients follow treatment courses generally featuring personally recommended formulations of high strength minoxidil from the range available from the dedicated pharmacies found in our Central and City of London hair loss clinics. As with many aspects of hair loss, the precise reason this vasodilator, which opens up the potassium channels, assists with hair growth is unknown. It has, however, been hugely successful for many people, producing notable regrowth Success Stories.

These types of clinical approaches, especially when backed by the on-going support of a personal hair loss specialist and regular monitoring, can often provide significant results without the need for surgical procedures.


The Belgravia Centre Hair Loss Clinic - Hair Loss Specialist ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 19 07 17A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

With lots of new growth visible, Frederik, pictured, is happy with the way treatment is going.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Share this article

Autoimmune Hair Loss Research Alopecia Areata StudyScientists in Canada think they may be on the verge of being able to “supress” over-reactive cells in the body that lead to autoimmune disorders such as Alopecia Areata, which causes sudden, patchy hair loss.

According to a new report from the team at the Research Institute of the McGill University Health Centre in Montreal, regulatory T Cells – also known as Tregs (“tee-regs”) – play a key role in managing the body’s response to potential threats. When Tregs are not functioning properly, the body can “over-react” and start attacking when there is no need. This is the essence of an autoimmune disorder.

Common cause of hair loss

Alopecia Areata is the second most common cause of hair loss after androgenetic alopecia – more commonly known as male and female pattern baldness. It is estimated to affect around three per cent of people at some point during their lifetime, worldwide.

It has a number of suspected triggers, including physical trauma (such as a car accident), shock and sudden extreme stress (such as a bereavement) and long-term psychological stres, though the underlying biological mechanism that causes this form of autoimmune hair loss remains unknown. Accordingly, people who visit a specialist clinic for Alopecia Areata treatment can be frustrated as to why they are not given a precise reason as to what caused their hair loss, only what is likely to have triggered the issue.

Like all autoimmune disorders, alopecia areata is complex, and research aiming to establish more about the enigmatic condition is underway in a number of countries. Additionally, as there are currently only effective alopecia areata treatment solutions for the patchy, scalp-only variant, the medical community is highly focused on helping those with the presently untreatable, more extreme versions Alopecia Totalis and Alopecia Universalis. These cause sudden hair fall from the whole head, and from head to toe respectively. By understanding more about how autoimmune hair loss works, it is more likely that effective treatments for all severities will be discovered. For this reason, research like that of the Canadian team is vital.

Areas of the Head and Body Affected By Alopecia Areata

Areas affected by autoimmune hair loss from Alopecia Areata, Alopecia Totalis and Alopecia Universalis are shown in blue

The researchers were investigating a rare mutation in a gene called FOXP3 which they found to affect the Treg cell’s ability to dampen the immune response. This, said the study’s lead author Dr Ciriaco Piccirillo, “results in the immune system overreacting and causing inflammation. This discovery gives us key insights on how Treg cells are born and how they can be regulated.”

His colleague, Khalid Bin Dhuban, added that: “Understanding this specific mutation has allowed us to shed light on how many milder forms of chronic inflammatory diseases or autoimmune diseases could be linked to alterations in FOXP3 functions.”

Inspired by its findings, the team went on to develop a molecule that could restore the Treg cells’ ability to control the immune system for patients with the same mutation. It has now been tested in animal models, and the researchers now hope to develop new drugs that will work with other conditions where defective Treg cells are thought to be an issue.

Immune system must be protected

What’s important, of course, is that new drugs don’t take things too far and inadvertently turn off the whole immune system. As Dr Piccirillo says: “Our goal is to increase the activity of these Treg cells in certain settings, such as autoimmune diseases, but we want to turn it down in other settings, such as cancer.”

While Alopecia Areata is just such an autoimmune disorder that might benefit from the team’s work, there appears a chance that developments in Treg research may even throw some light on possible new treatment options for genetic shedding conditions such as Male Pattern Hair Loss. A recent study by the University of California, San Francisco, found that defective Tregs may also play a part in genetic thinning, too.


Circ The Belgravia Centre Hair Loss Treatment for Alopecia AreataThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

“I came for a consultation appointment on Tuesday a week ago, 13th June and was very anxious and worried about my apparent hair loss and thinning having never expected to encounter this problem, having had actually what was considered ‘lovely hair’ all my life. I found the whole experience at your clinic positive and enjoyable.
Alexandra Berkeley was very knowledgeable and efficient and put me at ease. I had already investigated all possibilities as to what was going on with my hair, so I understood all what she was saying, and although she came out with the diagnosis of female pattern hair loss (which is something I wouldn’t like to have) it wasn’t a shock to find that out and the way she presented the diagnosis and outcome was professional and well dealt with and didn’t leave me feeling hopeless. Farzana Maudhoo was very helpful in taking me through my treatment recommendations and gave me good information about the costs options available to help with this. I found everyone on the reception desk and the general atmosphere at the centre a good experience. Also Alicia – a spanish lady who did my first clinical treatment therapy was lovely and provided a very relaxing treatment and said a lot to encourage me to stop worrying. And I have to say, for the first time in ages I woke up the next day feeling happy which has continued.”

Belgravia Centre City of London Hair Loss Clinic Liverpool Street

“I had a fantastic time yesterday during my first visit at Belgravia Centre Liverpool street. Mohammed checked my hair very professionally and advised me the best possible way to recover. Very gentle and helpful person. Cherie recommend good deal and reasonable options for treatment. Excellent atmosphere. But price should be considered in future for the long-term patients. The receptionist was very friendly and welcoming to every patients in the centre. Well mannered and helpful. Very good location and easy to pop in at anytime. Clean and attractive reception and building.”

“First off I thought the customer service was fantastic, from reception all the way to the specialists. Very friendly and helpful and did not make me feel uncomfortable. I was out of my comfort zone and felt welcomed as soon as I walked in. Would highly recommend to anyone. Mohammed was polite, knowledgeable and I felt as if I was in good hands. Keep up the good work. Many thanks.”

Share this article